M Holdings Securities Inc. bought a new stake in CVS Health Corporation (NYSE:CVS – Free Report) during the third quarter, HoldingsChannel.com reports. The fund bought 10,164 shares of the pharmacy operator’s stock, valued at approximately $890,000.
Other large investors have also added to or reduced their stakes in the company. Brighton Jones LLC lifted its holdings in CVS Health by 7.5% in the third quarter. Brighton Jones LLC now owns 19,160 shares of the pharmacy operator’s stock worth $1,642,000 after acquiring an additional 1,339 shares during the last quarter. American State Bank Iowa raised its position in shares of CVS Health by 9.5% during the 3rd quarter. American State Bank Iowa now owns 3,834 shares of the pharmacy operator’s stock worth $329,000 after purchasing an additional 333 shares during the period. Cullinan Associates Inc. lifted its holdings in shares of CVS Health by 15.2% in the 3rd quarter. Cullinan Associates Inc. now owns 53,469 shares of the pharmacy operator’s stock worth $4,582,000 after purchasing an additional 7,045 shares during the last quarter. Ethic Inc. lifted its holdings in shares of CVS Health by 6.7% in the 3rd quarter. Ethic Inc. now owns 48,352 shares of the pharmacy operator’s stock worth $4,143,000 after purchasing an additional 3,018 shares during the last quarter. Finally, StoneX Group Inc. boosted its position in CVS Health by 8.9% during the 3rd quarter. StoneX Group Inc. now owns 27,707 shares of the pharmacy operator’s stock valued at $2,374,000 after purchasing an additional 2,255 shares during the period. 80.66% of the stock is owned by institutional investors and hedge funds.
Key Headlines Impacting CVS Health
Here are the key news stories impacting CVS Health this week:
- Positive Sentiment: Zacks upgraded CVS to Rank #2 (Buy), citing improving optimism about the company’s earnings prospects. Article: All You Need to Know About CVS Health Rating Upgrade to Buy
- Positive Sentiment: Incoming CVS Pharmacy CEO Prem Shah reportedly purchased about $2 million of CVS shares, a notable show of confidence from an executive expected to lead one of the businesses after the separation. Article: CVS Health’s Future Pharmacy CEO Just Bought $2 Million of Stock
- Neutral Sentiment: CVS has announced plans to split into two companies by 2028. The restructuring could let each business focus more clearly on its operations, but the companies’ structure and the benefits to shareholders remain important unanswered questions. Article: CVS Health Announces Plan to Split Into Two Companies
- Negative Sentiment: Analyst estimates have become more cautious as the separation plan is factored in. One fair-value estimate was trimmed from $116.28 to $113.76, with execution risk and valuation concerns weighing on the outlook. Article: CVS Health Stock Fair Value Edges Lower on Separation Risk and Analyst Caution
Analyst Upgrades and Downgrades
Read Our Latest Report on CVS Health
CVS Health Stock Up 4.4%
CVS stock opened at $89.03 on Wednesday. The firm has a market cap of $113.92 billion, a PE ratio of 10.36, a P/E/G ratio of 0.74 and a beta of 0.58. CVS Health Corporation has a 12 month low of $69.51 and a 12 month high of $110.68. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.85 and a quick ratio of 0.66. The firm has a 50 day simple moving average of $90.12 and a 200 day simple moving average of $88.94.
CVS Health (NYSE:CVS – Get Free Report) last posted its quarterly earnings results on Wednesday, November 4th. The pharmacy operator reported $2.09 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.65 by $0.44. The firm had revenue of $108.40 billion for the quarter, compared to analyst estimates of $104.72 billion. CVS Health had a net margin of 2.62% and a return on equity of 13.65%. The firm’s quarterly revenue was up 5.4% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.60 earnings per share. Equities research analysts forecast that CVS Health Corporation will post 8.25 earnings per share for the current fiscal year.
CVS Health Announces Dividend
The business also recently announced a quarterly dividend, which was paid on Monday, November 2nd. Investors of record on Thursday, October 22nd were issued a $0.6650 dividend. This represents a $2.66 dividend on an annualized basis and a dividend yield of 3.0%. The ex-dividend date was Thursday, October 22nd. CVS Health’s payout ratio is presently 30.97%.
Insider Activity
In related news, EVP Prem Shah bought 23,855 shares of the business’s stock in a transaction dated Friday, November 6th. The shares were bought at an average cost of $83.89 per share, with a total value of $2,001,195.95. Following the completion of the transaction, the executive vice president directly owned 88,516 shares of the company’s stock, valued at approximately $7,425,607.24. This trade represents a 36.89% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. 0.85% of the stock is owned by insiders.
CVS Health Company Profile
CVS Health is a U.S.-based health care company that operates retail pharmacies, provides pharmacy benefit management services, and offers health insurance and other health services. Its businesses include CVS Pharmacy, pharmacy benefit manager CVS Caremark, and Aetna, its health benefits division. The company also provides care through MinuteClinic walk-in clinics and health care businesses including Oak Street Health and Signify Health. Its services span prescription fulfillment, pharmacy benefit management, health insurance, primary care, and in-home and community-based care.
See Also
- Five stocks we like better than CVS Health
- Why Kinder Morgan’s Chairman Just Bought $15 Million in Stock
- Rocket Lab’s Record Backlog Could Fuel a Rebound, But Neutron Raises the Stakes
- Don’t Let Their Low Yields Fool You: 3 Dividend Stocks Worth Watching
- A $4 Billion Jolt: NRG Energy Powers Data Center Ambitions
Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corporation (NYSE:CVS – Free Report).
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.
